Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

9.46
Delayed Data
As of Mar 24
 +0.24 / +2.60%
Today’s Change
2.60
Today|||52-Week Range
13.40
+7.62%
Year-to-Date
Array BioPharma's NDA for Cancer Drug Withdrawn; Shares Down
Mar 22 / Zacks.com - Paid Partner Content
Biotech Premarket Movers:
Mar 20 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
Mar 22 / Zacks.com - Paid Partner Content
3 Biotech Stock Rockets With More Fuel in the Tank
Mar 14 / MotleyFool.com - Paid Partner Content
How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More
Mar 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close9.22
Today’s open9.24
Day’s range9.15 - 9.58
Volume3,177,080
Average volume (3 months)4,268,629
Market cap$1.6B
Dividend yield--
Data as of 4:14pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-1,028.57%
Earnings growth (this year)-7.50%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+165.62%
P/E ratioNM
Price/Sales3.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SRPTSarepta Therapeutics...+0.25+0.84%
AERIAerie Pharmaceutical...+0.25+0.55%
SUPNSupernus Pharmaceuti...+1.55+5.46%
GBTGlobal Blood Therape...+0.60+1.56%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$137.9M
Annual profit (last year)-$92.8M
Net profit margin-67.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts


Search for Jobs